COVID-19 kit distribution in six Latin American countries: bureaucratic autonomy, populism, and evidence-based policymaking (2026)

Peer-Reviewed Study · Requejo Domínguez JA, Croke K, Wirtz VJ · 2026

Requejo Domínguez JA et al., 2026: Comparative policy study of government distribution of ivermectin-containing COVID-19 kits in Guatemala, Peru, Mexico, Costa Rica, Colombia and Argentina, documenting that the programmes happened and analysing why governments adopted them against expert advice.

We examine decision-making regarding the public distribution of COVID-19 kits containing ivermectin in six Latin American countries in 2020 and 2021, despite international scientific authorities advising against using these medicines outside of clinical trials.

Requejo Domínguez JA et al., 2026: Comparative policy study of government distribution of ivermectin-containing COVID-19 kits in Guatemala, Peru, Mexico, Costa Rica, Colombia and Argentina, documenting that the programmes happened and analysing why governments adopted them against expert advice. Comparative case-study policy analysis, six countries (Guatemala, Peru, Mexico, Costa Rica, Colombia, Argentina), 2020-21. No clinical population or dosing. Declared conflicts: none. Bearing CONTRADICTS the supportive reading of C3: the document confirms the Latin American programmes existed (which the claim asserts) but treats them as policy failures adopted against scientific advice , it is recorded for C3 because it is the best-sourced account of the Peru and other Latin American programmes, and it cuts against the claim that those programmes demonstrated benefit. Study type: other.